Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Debt to Equity (2020 - 2025)

Journey Medical's Debt to Equity history spans 6 years, with the latest figure at $0.79 for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 35.99% year-over-year to $0.79, compared with a TTM value of $0.79 through Dec 2025, down 35.99%, and an annual FY2025 reading of $0.79, down 35.99% over the prior year.
  • Debt to Equity for Q4 2025 was $0.79 at Journey Medical, down from $0.97 in the prior quarter.
  • The five-year high for Debt to Equity was $1988.4 in Q2 2023, with the low at -$1.28 in Q3 2021.
  • Average Debt to Equity over 5 years is $117.86, with a median of $1.13 recorded in 2024.
  • Year-over-year, Debt to Equity surged 467596.73% in 2023 and then crashed 99.91% in 2024.
  • Tracing DERM's Debt to Equity over 5 years: stood at $0.02 in 2021, then skyrocketed by 6843.66% to $1.34 in 2022, then tumbled by 46.42% to $0.72 in 2023, then surged by 72.53% to $1.24 in 2024, then crashed by 35.99% to $0.79 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Debt to Equity are $0.79 (Q4 2025), $0.97 (Q3 2025), and $1.3 (Q2 2025).